Tristel (TSTL) Competitors GBX 350 0.00 (0.00%) As of 12:28 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock TSTL vs. AMS, BVC, SPEC, AKR, CNSL, ODX, CTEC, CSRT, SLN, and AMYTShould you be buying Tristel stock or one of its competitors? The main competitors of Tristel include Advanced Medical Solutions Group (AMS), BATM Advanced Communications (BVC), INSPECS Group (SPEC), Akers Biosciences (AKR), Cambridge Nutritional Sciences (CNSL), Omega Diagnostics Group (ODX), ConvaTec Group (CTEC), Consort Medical plc (CSRT.L) (CSRT), Silence Therapeutics (SLN), and Amryt Pharma (AMYT). These companies are all part of the "medical" sector. Tristel vs. Advanced Medical Solutions Group BATM Advanced Communications INSPECS Group Akers Biosciences Cambridge Nutritional Sciences Omega Diagnostics Group ConvaTec Group Consort Medical plc (CSRT.L) Silence Therapeutics Amryt Pharma Advanced Medical Solutions Group (LON:AMS) and Tristel (LON:TSTL) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, community ranking, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations. Which has stronger valuation and earnings, AMS or TSTL? Advanced Medical Solutions Group has higher revenue and earnings than Tristel. Tristel is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdvanced Medical Solutions Group£132.18M2.88£11.22M£5.1634.22Tristel£42.24M3.96£6.54M£13.6625.61 Which has more volatility and risk, AMS or TSTL? Advanced Medical Solutions Group has a beta of 0.74, suggesting that its stock price is 26% less volatile than the S&P 500. Comparatively, Tristel has a beta of 0.23, suggesting that its stock price is 77% less volatile than the S&P 500. Is AMS or TSTL a better dividend stock? Advanced Medical Solutions Group pays an annual dividend of GBX 2 per share and has a dividend yield of 1.1%. Tristel pays an annual dividend of GBX 13 per share and has a dividend yield of 3.7%. Advanced Medical Solutions Group pays out 38.8% of its earnings in the form of a dividend. Tristel pays out 95.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Do insiders and institutionals believe in AMS or TSTL? 58.2% of Advanced Medical Solutions Group shares are owned by institutional investors. Comparatively, 50.4% of Tristel shares are owned by institutional investors. 3.1% of Advanced Medical Solutions Group shares are owned by company insiders. Comparatively, 4.9% of Tristel shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media favor AMS or TSTL? In the previous week, Advanced Medical Solutions Group had 2 more articles in the media than Tristel. MarketBeat recorded 2 mentions for Advanced Medical Solutions Group and 0 mentions for Tristel. Tristel's average media sentiment score of 1.03 beat Advanced Medical Solutions Group's score of 0.82 indicating that Tristel is being referred to more favorably in the news media. Company Overall Sentiment Advanced Medical Solutions Group Positive Tristel Positive Do analysts prefer AMS or TSTL? Advanced Medical Solutions Group presently has a consensus price target of GBX 300, indicating a potential upside of 69.88%. Given Advanced Medical Solutions Group's stronger consensus rating and higher possible upside, equities analysts clearly believe Advanced Medical Solutions Group is more favorable than Tristel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Advanced Medical Solutions Group 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Tristel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is AMS or TSTL more profitable? Tristel has a net margin of 15.47% compared to Advanced Medical Solutions Group's net margin of 8.49%. Tristel's return on equity of 20.43% beat Advanced Medical Solutions Group's return on equity.Company Net Margins Return on Equity Return on Assets Advanced Medical Solutions Group8.49% 4.57% 2.35% Tristel 15.47%20.43%9.89% Does the MarketBeat Community prefer AMS or TSTL? Advanced Medical Solutions Group received 19 more outperform votes than Tristel when rated by MarketBeat users. However, 57.36% of users gave Tristel an outperform vote while only 50.15% of users gave Advanced Medical Solutions Group an outperform vote. CompanyUnderperformOutperformAdvanced Medical Solutions GroupOutperform Votes16750.15% Underperform Votes16649.85% TristelOutperform Votes14857.36% Underperform Votes11042.64% SummaryAdvanced Medical Solutions Group beats Tristel on 11 of the 20 factors compared between the two stocks. Get Tristel News Delivered to You Automatically Sign up to receive the latest news and ratings for TSTL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TSTL vs. The Competition Export to ExcelMetricTristelMedical Instruments & Supplies IndustryMedical SectorLON ExchangeMarket Cap£167.20M£3.48B£5.44B£2.53BDividend Yield3.86%1.99%5.44%4.96%P/E Ratio25.6118.5922.14131.54Price / Sales3.96481.60389.70238,740.39Price / Cash20.96146.5438.2028.05Price / Book5.122.816.664.49Net Income£6.54M£99.80M£3.21B£5.82B7 Day PerformanceN/A2.82%5.83%8.73%1 Month Performance12.00%-3.70%-4.31%7.28%1 Year Performance-24.73%112.08%17.83%25.27% Tristel Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TSTLTristelN/AGBX 350flatN/A-24.4%£167.20M£42.24M25.61208Gap DownAMSAdvanced Medical Solutions Group2.2409 of 5 starsGBX 187.40-1.1%GBX 300+60.1%-7.8%£404.65M£132.18M36.3110News CoverageGap DownBVCBATM Advanced CommunicationsN/AGBX 13.95+3.1%N/A-26.1%£74.08M£130.32M-323.85980News CoverageGap UpSPECINSPECS GroupN/AGBX 41flatN/A-24.0%£41.69M£195.14M-10.151,673AKRAkers BiosciencesN/AN/AN/AN/A£21.64M£2.32M-0.44120CNSLCambridge Nutritional SciencesN/AGBX 2.56-5.2%N/AN/A£6.09M£9.77M-362.103,200Gap DownODXOmega Diagnostics GroupN/AN/AN/AN/A£5.23M£7.55M-220.0091Gap DownCTECConvaTec Group1.7604 of 5 starsGBX 259+0.2%GBX 301.67+16.5%-9.4%£6.59B£2.71B43.6210,000News CoverageCSRTConsort Medical plc (CSRT.L)N/AN/AN/AN/A£504.60M£298.60M127.85N/ASLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading VolumeAMYTAmryt PharmaN/AN/AN/AN/A£457.11M£210.24M-4.33290Gap Down Related Companies and Tools Related Companies Advanced Medical Solutions Group Competitors BATM Advanced Communications Competitors INSPECS Group Competitors Akers Biosciences Competitors Cambridge Nutritional Sciences Competitors Omega Diagnostics Group Competitors ConvaTec Group Competitors Consort Medical plc (CSRT.L) Competitors Silence Therapeutics Competitors Amryt Pharma Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:TSTL) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tristel plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Tristel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
